Formononetin inhibits IgE by huPlasma/PBMCs and mast cells/basophil activation via JAK/STAT/PI3-Akt pathways
RationaleFood allergy is a prevalent disease in the U.S., affecting nearly 30 million people. The primary management strategy for this condition is food avoidance, as limited treatment options are available. The elevation of pathologic IgE and over-reactive mast cells/basophils is a central factor i...
Prif Awduron: | Ibrahim Musa, Zhen-Zhen Wang, Nan Yang, Xiu-Min Li |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Frontiers Media S.A.
2024-08-01
|
Cyfres: | Frontiers in Immunology |
Pynciau: | |
Mynediad Ar-lein: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1427563/full |
Eitemau Tebyg
-
Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials
gan: Jiao Tian, et al.
Cyhoeddwyd: (2022-05-01) -
Anxiolytic effects of Formononetin in an inflammatory pain mouse model
gan: Xin-shang Wang, et al.
Cyhoeddwyd: (2019-04-01) -
Formononetin: A Pathway to Protect Neurons
gan: Xiaoyu Ma, et al.
Cyhoeddwyd: (2022-07-01) -
Related substance determination of formononetin by HPLC
gan: Xingyan PAN, et al.
Cyhoeddwyd: (2017-02-01) -
Formononetin: A Review of Its Anticancer Potentials and Mechanisms
gan: Kai-Ching Tay, et al.
Cyhoeddwyd: (2019-07-01)